Rimm DL - Search Results

1

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Among authors: rimm dl. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

2

Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.

Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Pierceall WE, et al. Oncogene. 1995 Oct 5;11(7):1319-26. Oncogene. 1995. PMID: 7478552

3

Transcriptional defects underlie loss of E-cadherin expression in breast cancer.

Ji X, Woodard AS, Rimm DL, Fearon ER. Ji X, et al. Among authors: rimm dl. Cell Growth Differ. 1997 Jul;8(7):773-8. Cell Growth Differ. 1997. PMID: 9218871

4

The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.

Dillon DA, D'Aquila T, Reynolds AB, Fearon ER, Rimm DL. Dillon DA, et al. Among authors: rimm dl. Am J Pathol. 1998 Jan;152(1):75-82. Am J Pathol. 1998. PMID: 9422525 Free PMC article.

5

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

6

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.

Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Rimm DL, et al. Am J Pathol. 1999 Feb;154(2):325-9. doi: 10.1016/s0002-9440(10)65278-9. Am J Pathol. 1999. PMID: 10027390 Free PMC article.

7

Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.

Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Garcia-Rostan G, et al. Among authors: rimm dl. Cancer Res. 1999 Apr 15;59(8):1811-5. Cancer Res. 1999. PMID: 10213482

8

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL. Chung GG, et al. Among authors: rimm dl. Clin Cancer Res. 2001 Dec;7(12):4013-20. Clin Cancer Res. 2001. PMID: 11751495

9

Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG, Reiss M. Xie W, et al. Among authors: rimm dl. Cancer Res. 2002 Jan 15;62(2):497-505. Cancer Res. 2002. PMID: 11809701

10

Reduced alpha-catenin and E-cadherin expression in breast cancer.

Rimm DL, Sinard JH, Morrow JS. Rimm DL, et al. Lab Invest. 1995 May;72(5):506-12. Lab Invest. 1995. PMID: 7745946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

512 results

Search Page

Filters